In this editorial, we comment a phase iii trial conducted by hutson et al. Fda label information for this drug is available at dailymed. Following oral administration of a 5mg radioactive dose of axitinib, approximately 41% of the radioactivity was recovered in feces and approximately 23% was recovered in urine. In other words, plugging the values into the iki ratio equation revealed medium risk for ddis, but a. This emedtv web selection takes a detailed look at this chemotherapy medicine, with information on how it is taken, how it works, safety issues, and more.
Inlyta may cause fertility problems in males and females, which may affect your ability to have a child. Based on mechanism of action and findings from animal studies, drug can cause fetal harm when administered to a pregnant woman. Further on in the same package label, in the full prescribing information, the drug interactions section. Take axitinib at around the same times every day, about 12 hours apart. Pdf the european medicines agency approval of axitinib inlyta. Axitinib is a more potent vegf receptor tyrosine kinase inhibitor tki, currently approved for second line treatment of metastatic rcc mrcc. Is caused by a defect in a gene called anaplastic lymphoma kinase alk and has spread to other parts of the body. Axitinib for the first line therapy of renal cancer. The atlas trial compared axitinib versus placebo in patients with. These highlights do not include all the information needed to use. Axitinib has the chemical name nmethyl23e2pyridin2ylvinyl1hindazol6ylsulfanylbenzamide. Axitinib is proposed for the treatment of renal cell carcinoma rcc, which, in the australian population, is the eighth and ninth most common cancer in males and females.
The molecular formula is c 22 h 18 n 4 os and the molecular weight is 386. Consistent clinical efficacy has been demonstrated across prognostic risk groups and prior therapeutic exposures. Talk to your healthcare provider if this is a concern for you. Pfizer presents promising new immunotherapy combination. This chemotherapy medication can cause potentially dangerous complications for some people, including those with certain allergies or people taking certain. Azacitidine is designed to slow the production of leukemia cells and help the bone marrow produce more healthy and normal functioning cells.
Grapefruit may interact with axitinib and lead to unwanted side effects. This medicine can pass into body fluids urine, feces, vomit. Just like when chemotherapy is given into the vein, this drug can be toxic, and exposure of the drug to others should be limited. When you enroll in pfizer oncology together, well connect you with a. Toxicity management of frontline pembrolizumab combined with. Axitinib is a second generation tyrosine kinase inhibitor with greater selective inhibition of vegf1, vegf2, and vegf3 only. Pdf axitinib is a tyrosine kinase inhibitor of vascular endothelial growth factor receptor 1 vegfr1. Pglycoprotein substrates and important missing information. Axitinib is in a class of medications called tyrosine kinase inhibitors tkis.
Substances that are inducers of cyp3a4 activity may increase metabolism and decrease. The solubility of axitinib in aqueous media over the range ph 1. Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice. The anticancer drug axitinib axt is a smallmolecule tyrosine kinasereceptor inhibitor of vegfr1, 2, and 3. Pdf axitinib for the management of metastatic renal cell. It is usually taken with or without food two times a day. Highlights of prescribing information these highlights do not include all the information needed to use sutent safely and effectively. Immune checkpoint inhibitors have improved clinical outcomes in many malignancies. Although axitinib is generally well tolerated, appropriate toxicity management is critical to maximizing drug delivery and optimizing treatment outcomes. Axitinib is used to treat late stage kidney cancer in patients who have received at least one cancer treatment that did not work well.
Axitinib is designed to slow the growth of cancer cells by inhibiting several mechanisms that the cell uses to grow and survive. Axitinib is a drug used to treat kidney cancer that has spread to other areas in the body. Axitinib therapy is commonly associated with transient elevations in serum aminotransferase that are generally mild and asymptomatic. Axitinib definition of axitinib by medical dictionary. Azacitidine is given to help increase blood cell counts, reduce the risk of infection, reduce the amount of blood transfusions needed, and decrease the risk of bleeding. Read the patient information leaflet if available from your pharmacist before you start using axitinib and each time you get a refill. Please see full prescribing information and patient information, which includes a. Inlyta axitinib tablets 2ndline mrcc treatment safety info. Tell your healthcare provider about all the medicines you take, including prescription and overthecounter medicines, vitamins, and herbal supplements. Further on in the same package label, in the full prescribing information, the drug interactions section identified various strong cyp3a45 inducers.
Axitinib versus placebo as an adjuvant treatment of renal cell. Inlyta is supplied as red, filmcoated tablets containing either 1 mg or 5 mg of axitinib together with microcrystalline cellulose, lactose monohydrate, croscarmellose sodium, magnesium. Hepatotoxicity see full prescribing information for complete boxed warning. Gilotrif is a prescription medicine used to treat people with nonsmall cell lung cancer nsclc, that has certain types of abnormal epidermal growth factor receptor egfr genes. Hypertension may be treated with a combination of standard antihypertensive therapy and axitinib dose reduction or interruption. Axitinib is metabolized primarily in the liver by cyp3a45 and to a lesser extent by cyp1a2, cyp2c19, and ugt1a1. Axitinib for treating advanced renal cell carcinoma after. It is used in patients whose disease has not gotten better with other chemotherapy axitinib is also being studied in the treatment of other types of cancer. Learn about inlyta axitinib tablets indicated for the treatment of advanced rcc.
It is not known if zykadia is safe and effective in children. Jakafi is indicated for treatment of intermediate or highrisk myelofibrosis mf, including primary mf, postpolycythemia vera mf and postessential thrombocythemia mf in adults. The same dosing reduction by one half is suggested in the package insert as a starting dose for patients with baseline moderate hepatic impairment childpugh class b. It has been shown to significantly inhibit growth of breast cancer in animal models and has shown partial responses in clinical trials with renal cell. If youve been diagnosed with advanced nonsmall cell lung cancer nsclc with common egfr mutations del19 or l858r, take the time to learn more about your condition and treatment options. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. The subsequent doses can be increased or decreased based on individual safety and. Axitinib inhibits several receptor tyrosine kinases including vegfr1, vegfr2, vegfr3, platelet derived growth factor receptor pdgfr, and ckit. Easy to read fda package insert, drug facts, dosage and administration, and adverse effects for tarceva erlotinib. Zykadia is a prescription medicine that is used to treat people with nonsmall cell lung cancer nsclc that. The recommended dose of xalkori in patients with preexisting moderate hepatic impairment any aspartate aminotransferase ast and total bilirubin greater than 1.
Caregivers should wear rubber gloves while cleaning up a patients body fluids, handling contaminated trash or laundry or changing diapers. Axitinib has a wellestablished role in the management of mrcc. In the event that this is not possible, the manufacturer recommends the dose of axitinib be reduced by one half. This medicine is available only with your doctors prescription. Antineoplastic pregnancy risk category d action inhibits receptor tyrosine kinases, including vascular endothelial growth factor receptors vegfr1, vegfr2, and vegfr3 at therapeutic plasma concentrations that are implicated in pathologic angiogenesis, tumor growth. Axitinib has a higher potency of inhibition in comparison to first generation tyrosine kinase inhibitors or pazopanib which may contribute to its better therapeutic window and decreased incidence of adverse effects. Please see full prescribing information for inlyta. Axitinib may need to be stopped until your wound heals after some surgeries. Inlyta is supplied as red, filmcoated tablets containing either 1 mg or 5 mg of axitinib together with microcrystalline.
1439 436 796 615 56 1152 1429 1037 925 964 1456 1017 963 121 104 678 1395 21 1450 1252 740 929 118 1444 497 430 355 321 1323 530 455 1179 1358 172 751 556 1031 1397 1291 137